Meriva
by Thorne Research Enjoy the benefits of curcumin in a unique, highly bioavailable new product from Thorne Research. It is commonly known that when taken orally curcumin is poorly absorbed. Meriva is a highly bioavailable curcumin extract that uses phytosome technology to significantly increase its absorption. Meriva Curcumin Phytosome is an advanced botanical extract that binds curcumin to phosphatidylcholine (a chief component of human cell membranes), and provides better bioavailability than any other curcumin extract available today. One capsule contains: Curcumin Phytosome** (root) (Curcuma longa extract / Phosphatidylcholine complex) 250 mg. *Daily Value (DV) not established. **Curcumin Phytosome (Meriva) complexed with Time-Sorb - a patent-pending, time-release matrix. Other ingredients: Suggested use: As a dietary supplement, take 2-4 capsules twice daily. The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide medical advice to individuals. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Click here for more information on Meriva About Meriva by Thorne Research Click here for more information on Meriva FAQs by Thorne Research Click here for more information on Meriva The Science by Thorne Research Addressing Inflammatory Bowel Disease by Hoffman Center Staff Arthritis: not for seniors only by Ronald Hoffman, M.D. Asthma update by Ronald Hoffman, M.D., C.N.S Atherosclerosis by Leyla Muedin, RD, CDN Cataracts: inevitable or avoidable? By Robert Abel, Jr., M.D. Fatty liver disease by Leyla Muedin, MS, RD, CDN Headaches: hunting down the cause of your pain by Hoffman Center Staff Hepatitis by Leyla Muedin, MS, RD, CDN Natural compounds that reduce cholesterol Skin disorders by Leyla Muedin, MS, RD, CDN Update on cancer by Ronald Hoffman, MD, CNS
|